Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yijiu Ren

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|March 22, 2021
Morphological Subtypes of Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: Prognostic Heterogeneity and Its Underlying MechanismHuikang Xie, Hang Su, Erjia Zhu, et al.
JAMA Network Open|June 4, 2020
Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer SurvivalYunlang She, Zhuochen Jin, Junqi Wu, et al.
Annals of Surgical Oncology|September 12, 2018
Lymph Node Micrometastasis Prognosticates Survival for Patients with Stage 1 Bronchogenic AdenocarcinomaYijiu Ren, Liyan Zhang, Huikang Xie, et al.
American Journal of Clinical Pathology|July 16, 2019
Use of Autofluorescence to Intraoperatively Diagnose Visceral Pleural Invasion From Frozen Sections in Patients With Lung Adenocarcinoma 2 cm or LessHuikang Xie, Hang Su, Donglai Chen, et al.
Quantitative Imaging in Medicine and Surgery|April 13, 2019
Quantitative features can predict further growth of persistent pure ground-glass noduleZhe Shi, Jiajun Deng, Yunlang She, et al.
Translational Lung Cancer Research|February 4, 2020
CT-based radiomics signature for the stratification of N2 disease risk in clinical stage I lung adenocarcinomaMinglei Yang, Yunlang She, Jiajun Deng, et al.
Oncotarget|April 9, 2016
The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expectedYijiu Ren, Chenyang Dai, Jianfei Shen, et al.
British Journal of Cancer|April 4, 2023
Development of the semi-dry dot-blot method for intraoperative detecting micropapillary component in lung adenocarcinoma based on proteomics analysisLong Xu, Hang Su, Shengnan Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2023
Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification to Upgrade Extracapsular Extension of Tumor in Nodes From R0 to Incomplete ResectionHuikang Xie, Chenyang Dai, Chang Gu, et al.
Therapeutic Advances in Medical Oncology|January 16, 2023
The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapyHaoran E, Junqi Wu, Yijiu Ren, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|March 22, 2021
Morphological Subtypes of Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: Prognostic Heterogeneity and Its Underlying MechanismHuikang Xie, Hang Su, Erjia Zhu, et al.
JAMA Network Open|June 4, 2020
Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer SurvivalYunlang She, Zhuochen Jin, Junqi Wu, et al.
Annals of Surgical Oncology|September 12, 2018
Lymph Node Micrometastasis Prognosticates Survival for Patients with Stage 1 Bronchogenic AdenocarcinomaYijiu Ren, Liyan Zhang, Huikang Xie, et al.
American Journal of Clinical Pathology|July 16, 2019
Use of Autofluorescence to Intraoperatively Diagnose Visceral Pleural Invasion From Frozen Sections in Patients With Lung Adenocarcinoma 2 cm or LessHuikang Xie, Hang Su, Donglai Chen, et al.
Quantitative Imaging in Medicine and Surgery|April 13, 2019
Quantitative features can predict further growth of persistent pure ground-glass noduleZhe Shi, Jiajun Deng, Yunlang She, et al.
Translational Lung Cancer Research|February 4, 2020
CT-based radiomics signature for the stratification of N2 disease risk in clinical stage I lung adenocarcinomaMinglei Yang, Yunlang She, Jiajun Deng, et al.
Oncotarget|April 9, 2016
The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expectedYijiu Ren, Chenyang Dai, Jianfei Shen, et al.
British Journal of Cancer|April 4, 2023
Development of the semi-dry dot-blot method for intraoperative detecting micropapillary component in lung adenocarcinoma based on proteomics analysisLong Xu, Hang Su, Shengnan Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2023
Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification to Upgrade Extracapsular Extension of Tumor in Nodes From R0 to Incomplete ResectionHuikang Xie, Chenyang Dai, Chang Gu, et al.
Therapeutic Advances in Medical Oncology|January 16, 2023
The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapyHaoran E, Junqi Wu, Yijiu Ren, et al.
Pageof 7